NRAS and acute lymphoblastic leukemia: The impact of NRAS mutations on childhood ALL relapse in our study cohort was slightly different from other groups (Ma et al., 2015; Irving et al., 2016), which might be explained by several factors, including but not limited to patient demographics, socioeconomic status, clinical characteristics, and study sample size.